diabetic maculopathyとは 意味・読み方・使い方

PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETIC MACULOPATHY例文帳に追加

糖尿病黄斑症の予防又は治療剤 - 特許庁

To provide a model animal with diabetic maculopathy, and a method for evaluating a medicine to the diabetic maculopathy by using the animal.例文帳に追加

糖尿病黄斑症のモデル動物並びに該動物を用いた糖尿病黄斑症に対する薬物の評価方法を提供する。 - 特許庁

The model animal with the diabetic maculopathy produced by subjecting a diabetic animal to intraocular ischemia/reperfusion to express edema in a retinal visual cell layer or in a macula lutea is provided.例文帳に追加

糖尿病動物に眼内虚血・再灌流処置を行い、網膜視細胞層又は黄斑部に浮腫を発現させた、糖尿病黄斑症のモデル動物。 - 特許庁

The method for evaluating the efficacy to the edema of the medicine includes administering a test medicine to the model animal with the diabetic maculopathy, and measuring the thickness of the retinal visual cell layer or the thickness and/or volume of the macula lutea.例文帳に追加

糖尿病黄斑症のモデル動物に被検薬物を投与し、網膜視細胞層の厚さの測定又は黄斑部の厚さ及び／又は体積の測定により、薬物の浮腫に対する有効性を評価する方法。 - 特許庁

Preferably, the model animal with the diabetic maculopathy is obtained by subjecting only one eye to the intraocular ischemia/reperfusion treatment, and has the treated eye and a non-treated eye in the same individual.例文帳に追加

好ましくは、眼内虚血・再灌流処置を片眼のみに行い、同一固体で処置眼と非処置眼を有する糖尿病黄斑症のモデル動物。 - 特許庁

The Suc-Val-Pro-HNCH(CH_2Ph)P(O)(OPh)_2 having the chymase- inhibiting action exhibits neovascularization-inhibiting action and is expected as a prophylactic or therapeutic agent for diseases in which neovascularization involves, particularly, intraocular neovascular diseases such as diabetic retinopathy, maculopathy, retinal vein blockage, premature infant retinitis and neovascular glaucoma.例文帳に追加

キマーゼ阻害作用を有するSuc-Val-Pro-HNCH(CH_2Ph)P(O)(OPh)_2は血管新生阻害作用を示し、血管新生が関与する疾患、特に糖尿病網膜症、黄斑変性症、網膜静脈閉塞症、未熟児網膜症、血管新生緑内障などの眼内血管新生性疾患の予防または治療剤として期待される。 - 特許庁